Table 1.

Altered HDL features in patients with ischemic stroke.

Altered feature	Phase		Reference
	Acute <24 h	>24 h
Protein content
↑ apoE, apoJ ↓ apoA-IV	x	x	Plubell et al. (126)
↓ apo A-I	x		Ortiz-Muñoz et al. (69)
↑ Inflammatory molecules: SAA2 SAA1	x	x x	Plubell et al. (126)
			Lepedda et al. (72)
↓ Paraoxonase-1 and other alterations in enzymes and proteins	x		Ortiz-Muñoz et al. (69)
	x		Varela et al. (70)
	x	x	Plubell et al. (126)
Size
Larger size	x		Ortiz-Muñoz et al. (69)
	x	x	Plubell et al. (126)
Anti-atherogenic properties
↓ Cholesterol efflux	x	x	Plubell et al. (126)
↓ Endothelial cell protection	x		Ortiz-Muñoz et al. (69)
↓ Anti-oxidant ability	x		Varela et al. (70)
	x		Damayanthi et al. (127)
↓Aanti-inflammatory properties	x		Ortiz-Muñoz et al. (69)
	x		Varela et al. (70)